Plasma lipoproteome in Alzheimer’s disease: a proof-of-concept study

被引：0
|
作者：
Danni Li
Fangying Huang
Yingchun Zhao
Peter W. Villata
Timothy J. Griffin
Lin Zhang
Ling Li
Fang Yu
机构：
[1] University of Minnesota,Department of Laboratory Medicine and Pathology
[2] University of Minnesota,Masonic Cancer Center
[3] University of Minnesota,Department of Biochemistry, Molecular Biology, and Biophysics
[4] University of Minnesota,Department of Biostatistics
[5] University of Minnesota,Department of Experimental and Clinical Pharmacology
[6] University of Minnesota,School of Nursing
来源：
Clinical Proteomics | 2018年 / 15卷
关键词：
Alzheimer’s disease; Plasma lipoproteins; Targeted proteomics; Complement C3; Very low-density lipoprotein (VLDL); Intermediate density lipoprotein (IDL); Low density lipoprotein (LDL); High-density lipoprotein (HDL); Biomarker; Diagnosis; Selected reaction monitoring (SRM);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Plasma lipoproteome in Alzheimer's disease: a proof-of-concept study
    Li, Danni
    Huang, Fangying
    Zhao, Yingchun
    Villata, Peter W.
    Griffin, Timothy J.
    Zhang, Lin
    Li, Ling
    Yu, Fang
    CLINICAL PROTEOMICS, 2018, 15
  • [2] Elevated Aβ aggregates in feces from Alzheimer's disease patients: a proof-of-concept study
    Pils, Marlene
    Dybala, Alexandra
    Schaffrath, Anja
    Rehn, Fabian
    Kutzsche, Janine
    Bloemeke, Lara
    Tusche, Markus
    Oezduezenciler, Pelin
    Bujnicki, Tuyen
    Kraemer-Schulien, Victoria
    Gramespacher, Hannes
    Schmieschek, Maximilian H. T.
    Barbe, Michael T.
    Onur, Oezguer A.
    Fink, Gereon R.
    Tamguney, Gultekin
    Bannach, Oliver
    Willbold, Dieter
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [3] Functional imaging of hippocampal dysfunction among persons with Alzheimer's disease: a proof-of-concept study
    Arciniegas, David B.
    Tregellas, Jason R.
    Rojas, Donald C.
    Hewitt, Burlleen
    Anderson, C. Alan
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 779 - 783
  • [4] Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease
    Koronyo, Yosef
    Biggs, David
    Barron, Ernesto
    Boyer, David S.
    Pearlman, Joel A.
    Au, William J.
    Kile, Shawn J.
    Blanco, Austin
    Fuchs, Dieu-Trang
    Ashfaq, Adeel
    Frautschy, Sally
    Cole, Gregory M.
    Miller, Carol A.
    Hinton, David R.
    Verdooner, Steven R.
    Black, Keith L.
    Koronyo-Hamaoui, Maya
    JCI INSIGHT, 2017, 2 (16)
  • [5] Analogy learning in Parkinson's disease: A proof-of-concept study
    Jie, Li-Juan
    Goodwin, Victoria
    Kleynen, Melanie
    Braun, Susy
    Nunns, Michael
    Wilson, Mark
    INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION, 2016, 23 (03): : 123 - 130
  • [6] Coordinated Reset Neuromodulation for Parkinson's Disease: Proof-of-Concept Study
    Adamchic, Ilya
    Hauptmann, Christian
    Barnikol, Utako Brigit
    Pawelczyk, Norbert
    Popovych, Oleksandr
    Barnikol, Thomas Theo
    Silchenko, Alexander
    Volkmann, Jens
    Deuschl, Guenter
    Meissner, Wassilios G.
    Maarouf, Mohammad
    Sturm, Volker
    Freund, Hans-Joachim
    Tass, Peter Alexander
    MOVEMENT DISORDERS, 2014, 29 (13) : 1679 - 1684
  • [7] Webcam-Based Eye-Tracking of Attentional Biases in Alzheimer's Disease: A Proof-Of-Concept Study
    Greenaway, Anne-Marie
    Hwang, Faustina
    Nasuto, Slawomir
    Ho, Aileen
    CLINICAL GERONTOLOGIST, 2024, 47 (01) : 98 - 109
  • [8] How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study
    Conte-Daban, Amandine
    Day, Adam
    Faller, Peter
    Hureau, Christelle
    DALTON TRANSACTIONS, 2016, 45 (39) : 15671 - 15678
  • [9] Combined Effect of tDCS and Motor or Cognitive Activity in Patients with Alzheimer's Disease: A Proof-of-Concept Pilot Study
    Fonte, Cristina
    Rotundo, Giorgia
    Varalta, Valentina
    Filosa, Angelica
    Muti, Ettore
    Barletta, Cosimo
    Evangelista, Elisa
    Venturelli, Massimo
    Picelli, Alessandro
    Smania, Nicola
    BRAIN SCIENCES, 2024, 14 (11)
  • [10] Can platelet BACE1 levels be used as a biomarker for Alzheimer's disease? Proof-of-concept study
    Decourt, Boris
    Walker, Aaron
    Gonzales, Amanda
    Malek-Ahmadi, Michael
    Liesback, Carolyn
    Davis, Kathryn J.
    Belden, Christine M.
    Jacobson, Sandra A.
    Sabbagh, Marwan N.
    PLATELETS, 2013, 24 (03) : 235 - 238
12345